ALAN ANCILLOTTI: Open Payments
NPI 1972845204 · RUTHERFORDTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 19 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $308 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Medtronic, Inc. | 1 | $37 |
| Viatris Specialty LLC | 1 | $35 |
| ABBVIE INC. | 2 | $34 |
| Exact Sciences Corporation | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, FARXIGA, Wegovy, VANTA ADAPTIVESTIM, YUPELRI, VRAYLAR, AIRSUPRA, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
